Filed a patent for "treatment of skin diseases and disorders using inhibitors of kallikrein-related peptidases (klk)" on Thu, October 26, 2023
New US Patent
xcur
almost 2 years ago
Filed a patent for "tumor necrosis factor receptor superfamily (tnfrsf) agonists, spherical nucleic acid (sna) tlr9 agonists and checkpoint inhibitors for antitumor therapy" on Thu, October 19, 2023
